SCHEMBL5480156

SCHEMBL5480156

Cn1cc(-c2cnc(N)c3c(C(=O)Nc4ccc(Oc5ccccc5)cc4)csc23)cn1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.68
BTK Q06187 9/20 0.68
AURKB Q96GD4 11/20 0.66
PLK4 O00444 5/20 0.61
AURKA O14965 5/20 0.61
MAP4K4 O95819 5/20 0.61
ABL1 P00519 5/20 0.61
NTRK1 P04629 5/20 0.61
INSR P06213 5/20 0.61
FYN P06241 5/20 0.61
CSF1R P07333 5/20 0.61
LYN P07948 5/20 0.61
MET P08581 5/20 0.61
FGFR1 P11362 5/20 0.61
SRC P12931 5/20 0.61
FLT1 P17948 5/20 0.61
RPS6KB1 P23443 5/20 0.61
EPHA2 P29317 5/20 0.61
BLK P51451 5/20 0.61
NEK2 P51955 5/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5472360 0.93 KDR (0.63) KDRBTKAURKBPLK4AURKA
SCHEMBL4762920 0.90 KDR (0.69) KDRBTKAURKBPLK4AURKA
SCHEMBL4821973 0.90 KDR (0.80) KDRBTKAURKBPLK4AURKA
SCHEMBL5474567 0.88 KDR (0.66) KDRBTKAURKBPLK4AURKA
SCHEMBL5475882 0.86 KDR (0.73) KDRBTKAURKBPLK4AURKA
SCHEMBL4827643 0.85 KDR (0.80) KDRBTKAURKBPLK4AURKA
SCHEMBL4760440 0.84 BTK (0.65) KDRBTKAURKBPLK4AURKA
SCHEMBL4761642 0.84 KDR (0.68) KDRBTKAURKBPLK4AURKA
SCHEMBL5470179 0.84 KDR (0.82) KDRBTKAURKBPLK4AURKA
SCHEMBL5472468 0.82 KDR (0.82) KDRBTKAURKBPLK4AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135387-A1 Inhibitors of protein kinases ABBOTT LABORATORIES 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135387-A1 Inhibitors of protein kinases MAP3K20, PACSIN2, MAP4K2 KDR 2196/4885BTK 373/4885AURKB 277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.